Zobrazeno 1 - 6
of 6
pro vyhledávání: '"59"'
Autor:
Duangkumpha, Kassaporn1,2, Stoll, Thomas3, Phetcharaburanin, Jutarop1,2, Yongvanit, Puangrat2, Thanan, Raynoo1, Techasen, Anchalee2,4, Namwat, Nisana1,2 watloi@yahoo.com, Khuntikeo, Narong2,5, Chamadol, Nittaya2,6, Roytrakul, Sittiruk7, Mulvenna, Jason3, Mohamed, Ahmed3, Shah, Alok K.3, Hill, Michelle M.3 michelle.hill@qimrberghofer.edu.au, Loilome, Watcharin1,2
Publikováno v:
PLoS ONE. 8/19/2019, Vol. 14 Issue 8, p1-17. 17p.
Autor:
Lim, Jeong-Hoon1, Lee, Chan-Hyeong2, Kim, Kyu Yeun1, Jung, Hee-Yeon1, Choi, Ji-Young1, Cho, Jang-Hee1, Park, Sun-Hee1, Kim, Yong-Lim1, Baek, Moon-Chang2, Park, Jae Berm3, Kim, Young-Hoon4, Chung, Byung Ha5, Lee, Sang-Ho6, Kim, Chan-Duck1 drcdkim@knu.ac.kr
Publikováno v:
PLoS ONE. 9/18/2018, Vol. 13 Issue 9, p1-17. 17p.
Autor:
Skeie, Jessica M.1,2,3, Aldrich, Benjamin T.1,2,3, Goldstein, Andrew S.1,2, Schmidt, Gregory A.2,3, Reed, Cynthia R.2,3, Greiner, Mark A.1,2,3 mark-greiner@uiowa.edu
Publikováno v:
PLoS ONE. 3/12/2018, Vol. 13 Issue 3, p1-18. 18p.
Autor:
Miyauchi, Eisuke1, Furuta, Takuya2,3, Ohtsuki, Sumio4, Tachikawa, Masanori1, Uchida, Yasuo1, Sabit, Hemragul3, Obuchi, Wataru1, Baba, Tomoko1, Watanabe, Michitoshi1, Terasaki, Tetsuya1 terasaki.tetsuya@m.tohoku.ac.jp, Nakada, Mitsutoshi3
Publikováno v:
PLoS ONE. 3/7/2018, Vol. 13 Issue 3, p1-22. 22p.
Autor:
Carreras-Planella, Laura1,2, Soler-Majoral, Jordi1,3,4, Rubio-Esteve, Cristina1,3, Lozano-Ramos, Sara Inés1,2, Franquesa, Marcella1,3, Bonet, Josep1,3, Troya-Saborido, Maria Isabel1,3 mitroya.germanstrias@gencat.cat, Borràs, Francesc Enric1,2,3 feborras@igtp.cat
Publikováno v:
PLoS ONE. 5/10/2017, Vol. 12 Issue 5, p1-20. 20p.
Autor:
Katharina Fink, Carl Hamsten, Sahl Khalid Bedri, Anna Glaser, Ali Manouchehrinia, Jan Hillert, Tomas Olsson, Burcu Ayoglu, Hans Grönlund, Ola Nilsson, Anna Månberg, Peter Nilsson
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217208 (2019)
PLoS ONE
PLoS ONE
Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affini